Medspoke

Talks (17)

AV in CLL

Feb 25

Frontline BTK Inhibitor Therapy

Feb 20

Acalabrutinib in Older and/or Frail Patients with CLL

Feb 06

CNS Involvement in CLL

Feb 02

Zanu + Ven in Poor Risk CLL

Feb 02

Zanu/Sonrotoclax in CLL

Feb 02

inMIND Trial

Feb 02

Epcoritamab in CLL

Feb 02

AMPLIFY Phase III Trial

Feb 02

Lisaftoclax in CLL

Jan 19

Rocbrutinib

Jan 19

Resistance to Pirtobrutinib

Jan 17

BGB-16673 in CLL

Jan 17

Limited duration acalabrutinib

Jan 17

Pirtobrutinib vs BR in CLL

Jan 17

Bexobrutideg in CLL

Jan 17

Pirtobrutinib vs Ibrutinib in CLL

Jan 16